Cargando…
Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol
INTRODUCTION: Clinical practice guidelines (CPGs) are designed to reduce inappropriate clinical variation and improve the quality of care. Barriers to CPGs include a lack of awareness of CPGs, access to them, time pressures and concerns regarding the evidence underpinning CPG development, implementa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103843/ https://www.ncbi.nlm.nih.gov/pubmed/32205377 http://dx.doi.org/10.1136/bmjopen-2019-035448 |
_version_ | 1783512123919302656 |
---|---|
author | Bierbaum, Mia Braithwaite, Jeffrey Arnolda, Gaston Delaney, Geoffrey P Liauw, Winston Kefford, Richard Tran, Yvonne Nic Giolla Easpaig, Bróna Rapport, Frances |
author_facet | Bierbaum, Mia Braithwaite, Jeffrey Arnolda, Gaston Delaney, Geoffrey P Liauw, Winston Kefford, Richard Tran, Yvonne Nic Giolla Easpaig, Bróna Rapport, Frances |
author_sort | Bierbaum, Mia |
collection | PubMed |
description | INTRODUCTION: Clinical practice guidelines (CPGs) are designed to reduce inappropriate clinical variation and improve the quality of care. Barriers to CPGs include a lack of awareness of CPGs, access to them, time pressures and concerns regarding the evidence underpinning CPG development, implementation and dissemination. The objectives of this study are to assess clinicians’ attitudes to CPGs for cancer treatment and the perceived barriers to and facilitators of CPG adherence in order to inform the implementation of cancer treatment CPGs. METHODS AND ANALYSIS: A mixed methods study will be conducted using a three-phase, sequential design, with each phase informing the next. In phase 1, a qualitative study using recorded interviews will investigate clinicians’ attitudes to CPGs for cancer treatment and perceptions of barriers and facilitators to CPG adherence (n=30); interview transcripts will be analysed thematically. In phase 2, a survey will quantify the frequency of attitudes, barriers and facilitators identified in phase 1, in a broader clinical sample (n=200). In phase 3, a workshop forum will be held to facilitate discussions examining the implications of phase 1 and 2 findings for cancer CPG implementation strategies (n=40) leading to recommendations for improvements to practice. The workshop discussion will be recorded, and the transcript will be analysed thematically. ETHICS AND DISSEMINATION: This study has received ethics approval in New South Wales, Australia (2019/ETH11722, #52019568810127). Study findings will be published in peer-reviewed journals and will form part of a doctoral thesis and be presented at national and international conferences. |
format | Online Article Text |
id | pubmed-7103843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-71038432020-03-31 Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol Bierbaum, Mia Braithwaite, Jeffrey Arnolda, Gaston Delaney, Geoffrey P Liauw, Winston Kefford, Richard Tran, Yvonne Nic Giolla Easpaig, Bróna Rapport, Frances BMJ Open Oncology INTRODUCTION: Clinical practice guidelines (CPGs) are designed to reduce inappropriate clinical variation and improve the quality of care. Barriers to CPGs include a lack of awareness of CPGs, access to them, time pressures and concerns regarding the evidence underpinning CPG development, implementation and dissemination. The objectives of this study are to assess clinicians’ attitudes to CPGs for cancer treatment and the perceived barriers to and facilitators of CPG adherence in order to inform the implementation of cancer treatment CPGs. METHODS AND ANALYSIS: A mixed methods study will be conducted using a three-phase, sequential design, with each phase informing the next. In phase 1, a qualitative study using recorded interviews will investigate clinicians’ attitudes to CPGs for cancer treatment and perceptions of barriers and facilitators to CPG adherence (n=30); interview transcripts will be analysed thematically. In phase 2, a survey will quantify the frequency of attitudes, barriers and facilitators identified in phase 1, in a broader clinical sample (n=200). In phase 3, a workshop forum will be held to facilitate discussions examining the implications of phase 1 and 2 findings for cancer CPG implementation strategies (n=40) leading to recommendations for improvements to practice. The workshop discussion will be recorded, and the transcript will be analysed thematically. ETHICS AND DISSEMINATION: This study has received ethics approval in New South Wales, Australia (2019/ETH11722, #52019568810127). Study findings will be published in peer-reviewed journals and will form part of a doctoral thesis and be presented at national and international conferences. BMJ Publishing Group 2020-03-23 /pmc/articles/PMC7103843/ /pubmed/32205377 http://dx.doi.org/10.1136/bmjopen-2019-035448 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Oncology Bierbaum, Mia Braithwaite, Jeffrey Arnolda, Gaston Delaney, Geoffrey P Liauw, Winston Kefford, Richard Tran, Yvonne Nic Giolla Easpaig, Bróna Rapport, Frances Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title | Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title_full | Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title_fullStr | Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title_full_unstemmed | Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title_short | Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
title_sort | clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103843/ https://www.ncbi.nlm.nih.gov/pubmed/32205377 http://dx.doi.org/10.1136/bmjopen-2019-035448 |
work_keys_str_mv | AT bierbaummia cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT braithwaitejeffrey cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT arnoldagaston cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT delaneygeoffreyp cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT liauwwinston cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT keffordrichard cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT tranyvonne cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT nicgiollaeaspaigbrona cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol AT rapportfrances cliniciansattitudestooncologyclinicalpracticeguidelinesandthebarriersandfacilitatorstoadherenceamixedmethodsstudyprotocol |